Indication Approved for Merit Medical’s EmboCube and Torpedo for Embolization to Occlude Blood Flow
February 3, 2020—Merit Medical Systems, Inc. announced that both its EmboCube and Torpedo devices are now FDA indicated for the embolization of blood vessels to occlude blood flow, which helps control bleeding and hemorrhaging in the peripheral vasculature.
Randomized, Sham-Controlled Trial Demonstrates Efficacy of Prostate Artery Embolization for Symptomatic BPH
December 16, 2019—A study published online ahead of print in European Urology evaluating prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH) found that the “clearly superior efficacy” of PAE compared with a sham procedure supports the use of PAE in patients with typical symptoms associated with BPH.
Varian to Acquire Oncozene and Embozene Embolic Bead Lines From Boston Scientific
July 2, 2019—Varian Medical Systems, Inc. continued to expand its interventional oncology/embolic portfolio, announcing plans to acquire Boston Scientific's drug-loadable microsphere and bland embolic bead product lines for treating arteriovenous malformations and hypervascular tumors.
QXMédical Licenses Bioresorbable Embolic Technology From University of Minnesota
June 10, 2019—QXMédical announced that it has acquired the worldwide exclusive rights to the bioresorbable embolic technology developed at the University of Minnesota for resorbable and drug-loadable microspheres and hydrogels to be marketed to interventional radiologists and oncologists to occlude vessels for a variety of clinical indications.
Study Compares Different Sizes of Microspheres for Embolization to Treat BPH
May 30, 2019—Results of a single-center study comparing the safety and efficacy of prostatic artery embolization (PAE) using trisacryl gelatin microspheres of different sizes for treatment of benign prostatic hyperplasia (BPH) were published by Daniel Torres, MD, et al in Journal of Vascular and Interventional Radiology (JVIR; 2019;30:638–644).
Multisociety Position Statement Supports PAE to Treat Lower Urinary Tract Symptoms Attributed to BPH
April 19, 2019—A multisociety consensus position statement on prostate artery embolization (PAE) for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) was published by Justin P. McWilliams, MD, et al in Journal of Vascular and Interventional Radiology (JVIR).
Nylon Fibered Versus Nonfibered Embolization Coils Compared in Porcine Study
April 10, 2019—A study to determine whether nylon fibers improve the performance of platinum embolization coils in porcine arteries was published by Scott O. Trerotola, MD; Gary A. Pressler, PhD; and Christopher Premanandan, DVM, online ahead of print in Journal of Vascular and Interventional Radiology (JVIR). The platinum embolization coils, guidewires, and catheters used were from Cook Medical, which funded the study.
Bariatric Embolization Evaluated in BEAT Obesity Study
April 3, 2019—An evaluation of the safety and efficacy of bariatric embolization in severely obese adults at up to 12 months after the procedure concluded that the treatment is well tolerated and induces appetite suppression and weight loss for this time period.
Mentors and Protégés: Conversations on Career and Craft With Riad Salem, MD
Alexander Logsdon, DO, and Adam Sucher, DO, talk with Dr. Salem about balancing research and clinical responsibilities, his journey in establishing Y-90 as a standard of care, and his advice to aspiring clinical researchers, among other topics.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.
January 2020 Supplement